Sleeping Beauty (SB) is the most active Tc1/ mariner-type transposon in vertebrates. SB contains two transposase-binding sites (DRs) at the end of each terminal inverted repeat (IR), a feature termed the IR/DR structure. We investigated the involvement of cellular proteins in the regulation of SB transposition. Here, we establish that the DNAbending, high-mobility group protein, HMGB1 is a host-encoded cofactor of SB transposition. Transposition was severely reduced in mouse cells de®cient in HMGB1. This effect was rescued by transient over-expression of HMGB1, and was partially complemented by HMGB2, but not with the HMGA1 protein. Over-expression of HMGB1 in wildtype mouse cells enhanced transposition, indicating that HMGB1 can be a limiting factor of transposition. SB transposase was found to interact with HMGB1 in vivo, suggesting that the transposase may recruit HMGB1 to transposon DNA. HMGB1 stimulated preferential binding of the transposase to the DR further from the cleavage site, and promoted bending of DNA fragments containing the transposon IR. We propose that the role of HMGB1 is to ensure that transposase±transposon complexes are ®rst formed at the internal DRs, and subsequently to promote juxtaposition of functional sites in transposon DNA, thereby assisting the formation of synaptic complexes.
INTRODUCTION
The use of transposable elements as genetic tools contributed signi®cantly to our understanding of biological systems. In vertebrates, such tools could be applied to both research and therapeutics. Tc1/mariner elements are probably the most widespread transposons in nature (1) . These elements are able to transpose in species other than their hosts, and are therefore emerging tools for functional genomics in several organisms (1) . However, the vast majority of naturally occurring Tc1/ mariner-like transposons are non-functional due to inactivating mutations. In vertebrates, not a single active element has been found. Based on a comparative phylogenetic approach, we have reconstructed an active Tc1-like transposon from bits and pieces of inactive elements found in the genomes of teleost ®sh, and named this transposon Sleeping Beauty (SB) (2) .
SB is¯anked by~230 bp terminal inverted repeats (IRs), which contain binding sites for the enzymatic factor of transposition, the transposase. The transposase binding sites (DRs) of SB elements are repeated twice per IR in a direct orientation (2) . This special organization of IR, termed IR/DR, is an evolutionarily conserved feature of a group of Tc1-like transposons, but not that of the Tc1 element itself (1, 3) . In addition to the DRs, the left IR of SB contains a transpositional enhancer-like sequence, termed HDR (4) . Speci®c binding to the DRs is mediated by an N-terminal, paired-like DNAbinding domain of the transposase (2, 4, 5) . The catalytic domain of the transposase, responsible for the DNA cleavage and joining reactions, is characterized by a conserved amino acid triad, the DDE motif, which is found in a large group of recombinases (6) , including retroviral integrases and the RAG1 V(D)J recombinase involved in immunoglobulin gene rearrangements (1) .
SB transposes via a DNA intermediate, through a cut-andpaste mechanism. The transposition process can arbitrarily be divided into at least four major steps: (i) binding of the transposase to its sites within the transposon IRs; (ii) formation of a synaptic complex in which the two ends of the elements are paired and held together by transposase subunits; (iii) excision from the donor site; (iv) reintegration at a target site. On the molecular level, mobility of DNA-based transposable elements can be regulated by imposing constraints on transposition. One important form of transpositional control is represented by regulatory`checkpoints', at which certain molecular requirements have to be ful®lled for the transpositional reaction to proceed. These requirements can operate at any of the four different stages of transposition listed above, and can be brought about by both element-and host-encoded factors.
Several DNA recombination reactions are stimulated by DNA-bending proteins. For example, the transposase binding sites of bacteriophage Mu are brought together by the bending action of the Escherichia coli HU protein (7) . Hin recombinase-mediated recombination and bacteriophage l integration are strongly stimulated by HU (8) and integration host factor (IHF) (9) mobility group (HMG) proteins can functionally replace HU and IHF in some recombination reactions, indicating some level of exchangeability between these DNA-bending proteins (10) . All of these DNA-bending proteins are believed to assist recombinational mechanisms by facilitating the formation of active recombinase±DNA complexes (11, 12) . HMG proteins are classi®ed into three subfamilies, HMGB1/2 (formerly known as HMG1/2), HMGA1a/b (formerly known as HMGI/Y) and HMGN1/2 (formerly known as HMGB14/17, that share many physical characteristics, but differ in their main functional domains (13) . Both the HMGB and HMGA1 group proteins are known to bind A/T-rich DNA through interactions with the minor groove of the DNA helix (12) . HMGB1 is an abundant (~10 6 molecules/cell), nonhistone, nuclear protein associated with eukaryotic chromatin (12) . Through its DNA-binding domain, termed the HMGbox, HMGB1 binds DNA in a sequence-independent manner, but with preference for certain DNA structures including fourway junctions and severely undertwisted DNA (13±16). HMGB1 has low af®nity to B-form DNA, and is thought to be recruited by other DNA-binding proteins through protein± protein interactions, and induce a local distortion of the DNA upon binding. The ability of HMGB1/2 proteins to bend DNA was demonstrated in vitro (13) . These proteins facilitate selfligation of short DNA fragments (17, 18) , and can bridge linear DNA fragments thereby enhancing multimerization of longer DNAs (19) . Together with the closely related HMGB2 protein, HMGB1 has been implicated in a number of eukaryotic cellular processes including gene regulation, DNA replication and recombination (12, 20) . HMGB1/2 directly interact with a number of proteins, including some HOX (21) and POU domain (22) transcription factors and the TATA-binding protein (23) , and facilitate their binding through protein±protein interactions. HMGB1/2 were shown to enhance immunoglobulin V(D)J recombination by enforcing speci®c DNA recognition (24) through their interaction with the RAG1/2 recombinase complex (25) , and facilitating cleavage (24) . In addition, HMGB1 was found to promote Rep protein-mediated site-speci®c cleavage of adeno-associated virus DNA (26) . The production of retroviral cDNA does not require an excision step, but the downstream events of retroviral integration are highly similar to other transpositional reactions (27) . Interestingly, HMGA1 family members, but not HMGB1/2, are required for retroviral cDNA integration (28, 29) . Both V(D)J recombination and retroviral integration have common features with SB transposition. RAG-mediated cleavage at the ends of recombination signal sequences (RSSs) in V(D)J recombination is probably analogous to the excision step of transposition, whereas the biochemical steps leading to insertion of signal molecules, retrovirus integration and DNA transposition are essentially the same (27) .
SB mediates transposition in a variety of vertebrate species (30) , and is more active than other members of the Tc1/ mariner family (31) . Because there is substantial interest in developing transposon technology for gene therapy (32) and gene discovery (31) , it is of importance to dissect the molecular mechanisms involved in transposition and its regulation. In particular, differential interactions between the transposon and host-encoded factors may result in limitation of host range. In this work, we evaluated HMG proteins as cellular host factors of SB transposition in mammalian cells.
We have found that HMGB1 is required for ef®cient SB transposition. SB transposition was signi®cantly reduced in HMGB1-de®cient mouse cells. This effect was fully complemented by expressing HMGB1, partially by expressing HMGB2, but not with HMGA1. Interestingly, transient over-expression of HMGB1 in wild-type mouse cells enhanced transposition, indicating that HMGB1 is a limiting factor of transposition. SB transposase was found to interact with HMGB1 in vivo, suggesting that the transposase may actively recruit HMGB1 to transposon DNA via protein± protein interactions. HMGB1 enhanced preferential binding of the SB transposase to the internal transposase binding sites within the transposon IRs, and promoted bending of DNA fragments comprising the transposon IRs. These data are consistent with a role of HMGB1 in synaptic complex formation in transposition.
MATERIALS AND METHODS
Protein expression, puri®cation and electrophoretic mobility shift assay (EMSA)
Production of N123 was done as described (2) . A plasmid expressing a hexahistidine-tagged version of HMGB1 was described in Aidinis et al. (25) , and was kindly provided by M. Bianchi, Milan, Italy. Protein expression was induced by the addition of 0.4 mM IPTG in E.coli BL21 cells. Puri®cation was done using a nickel resin (Qiagen), according to the manufucturer's protocol. The puri®ed protein was dialyzed against 25 mM HEPES pH 7.4, 10% glycerol, 1 M NaCl and 2 mM b-mercaptoethanol, and its concentration determined by sodium dodecyl sulphate (SDS)±polyacrylamide gel electrophoresis.
The plasmid expressing a maltose-binding protein (MBP)±SB transposase fusion protein was made by cloning the SB transposase gene into the XmnI/EcoRI sites of pAMLc2X (NEB). The plasmid was transformed into the BL21-CodonPlus-RIL E.coli strain (Stratagene). Protein puri®cation protocol was as described by the manufacturer of the amylose resin (NEB). A 1 l bacterial culture was grown to OD (A 600 ) 0.5, IPTG was added to a ®nal concentration of 0.3 mM, and further incubated at 37°C for 2 h. Cells were harvested and resuspended in 30 ml of column buffer (CB = 20 mM Tris pH 7.4, 200 mM NaCl, 1 mM EDTA and 1 mM DTT). Before cell lysis, 0.6 mg DNase I and 0.5% (v/v) polyethyleneimine was added. Cell lysis was done by French press at 1200 p.s.i., and the pellet obtained after centrifugation was resuspended in 50 ml CB containing 750 mM NaCl. In the higher ionic strength buffer, MBP±SB was dissolved, but nucleic acids and some other proteins remained in the pellet. The supernatant was diluted 1:5 with CB and loaded on an amylose resin column (12 ml of resin equilibrated with column buffer) with ā ow rate not exceeding 1 ml/min. Washing was done with 12 column vol of wash buffer (CB with 750 mM NaCl). The fusion protein was eluted with elution buffer (20 mM Tris pH 7.4, 750 mM NaCl, 1 mM EDTA, 1 mM DTT and 10 mM maltose), 25 fractions of 2 ml each were collected; the fractions having the fusion protein were pooled and concentrated to 0.4 mg/ml. An EcoRI fragment comprising the left IR of the SB element containing both transposase binding sites, an A¯II/HindIII fragment containing only the inner DR (IDR), and an EcoRI/ HindIII fragment of a modi®ed SB element lacking the IDR, and thus containing only the outer DR (ODR) (30) , were endlabeled using [a 32 P]dATP and Klenow. Equal amounts of DNA fragments were used for labeling. Nucleoprotein complexes were formed in 20 mM HEPES (pH 7.5), 0.1 mM EDTA, 0.1 mg/ml BSA, 150 mM NaCl, 1 mM DTT in a total volume of 10 ml. Reactions contained~0.08 nM DNA probe, 1 mg poly(dI)(dC), 75 nM HMGB1 and 0.2, 0.1 or 0.05 ng N123. Reactions with MBP±SB transposase fusion contained 0.1 nM of left IR probe (EcoRI fragment) and either 2 nM or 20 nM of puri®ed MBP±SB with or without 0.1 or 1 mM of puri®ed HMGB1. After a 15 min incubation on ice, 5 ml of loading dye containing 50% glycerol and bromophenol blue was added, and the samples loaded onto a 5% polyacrylamide gel. Radioactive bands were quanti®ed using a Molecular Dynamics PhosphorImager System.
Ligase-mediated circularization assay
A 32 P-labeled left IR fragment (~0.04 nM) with cohesive EcoRI ends was pre-incubated with 6 nM HMGB1 on ice for 20 min in T4 DNA ligase buffer, in a ®nal volume of 50 ml. The ligation reaction was initiated by the addition of 0.025 U of T4 DNA ligase (NEB), and incubated at 16°C. Aliquots of 9 ml of the reaction mixture were withdrawn at different time points (0, 5, 15, 30 and 60 min), and were added to 41 ml of stop solution (0.5% SDS, 10 mM EDTA, 1 mg/ml Proteinase K). The reactions were incubated at 50°C for 2 h, extracted with phenol/chloroform/isoamyl alcohol, and then with chloroform/isoamyl alcohol. Aliquots of 30 ml of the 60 min sample were taken, and digested with 100 U of Exonuclease III (ExoIII) (NEB) at 37°C for 30 min. Aliquots of 25 ml of each extracted sample were run on a 4% non-denaturing polyacrylamide gel, gels were dried and autoradiographed at ±80°C.
For bacterial transformations,~0.1 nM linearized transposon DNA was pre-incubated with 12 nM HMGB1, then 1 U/reaction of the T4 DNA ligase was added, and the reaction allowed to proceed for 0, 15, 30 and 60 min. Reactions were terminated by the addition of stop solution, the DNA was precipitated, resuspended in TE, and electroporated into DH10B E.coli cells.
Immunoprecipitation
Nuclear extracts from~2.0 Q 10 7 IRES-SB and IRES-K cells were prepared essentially as described previously (30) . The nuclear extract was diluted to contain 100 mM NaCl with binding buffer [25 mm HEPES±KOH pH 7.9, 1.5 mM MgCl 2 , 10 mm KCl, 0.5 mM EDTA, 0.2 mM DTT, 0.1 mM NP-40, 12% glycerol, 1Q complete protease inhibitors (Roche)]. For the DNase I treatment, MgCl 2 concentration was increased to 6 mM and 6 U of DNase I (Ambion) was added. The extract was incubated at 23°C for 30 min, followed by the addition of 2 ml of 500 mM EDTA. The extract was precleared in two steps, ®rst by adding 1 mg mouse IgG and 20 ml Protein G-Sepharose (50% slurry in PBS) for 60 min at 4°C, and then by adding 50 ml Protein G-Sepharose followed by an overnight incubation at 4°C. Immunoprecipitation was performed using 1 mg HMGB1 antibody (Santa Cruz Biotech.), or actin antibody (clone ACTN05, Neomarkers), or p15 antibody (R-20, Santa Cruz Biotech.), or goat preimmune serum (Sigma) and 15 ml Protein G-Sepharose (50% slurry in PBS). The tubes were rotated overnight at 4°C. The beads were washed four times in PBS, resuspended in SDS sample buffer, and subjected to western hybridization with a rabbit polyclonal antibody against the SB transposase.
Co-immunoprecipitation was done using puri®ed HMGB1 (1 mM) and puri®ed MBP±SB (0.2 mM), either alone or together in 20 ml ®nal volume in binding buffer containing 25 mM HEPES (pH 7.5), 10 mM MgCl 2 , 1 mM DTT, 2% glycerol, 0.25 mg BSA, 50 mM KCl, 0.01% NP-40 for 20 min at 4°C. Then~1 nM of a 32 P-labeled transposon fragment containing the left IR (~120 000 c.p.m.) was added, and the reaction continued for a further 45 min. One microgram of either anti-HMGB1 or anti-SB was added, and the incubation continued for 2 h at 4°C with rotation. Protein A-and Protein G-Sepharoses were pretreated with the binding buffer containing 500 mg/ml of herring sperm DNA overnight. An aliquot of 50 ml pretreated Protein A-Sepharose was added to the anti-SB samples, 50 ml of pretreated Protein G-Sepharose was added to the anti-HMGB1 samples, and incubation continued for 3 h at 4°C. The immunoprecipitate was washed three times with the binding buffer. Radioactivity of the DNA that remained bound to the beads was quanti®ed with a liquid scintillation counter.
Cell culture and in vivo transposition assay
Cell lines were grown in DMEM supplemented with 10% fetal bovine serum. Wild-type (VA1) and HMGB1-de®cient (C1) mouse embryonic ®broblast (MEF) cell lines have been described previously (33) , and were kindly provided by M. Bianchi, Milan, Italy. All DNA transfections were done with FUGENE6 transfection reagent (Roche, Germany). Cells were cotransfected with 90 ng each of pCMV-SB (2) and pT/zeo, (30) and 500 ng plasmid expressing HMGB1 (25), HMGB2 (25) , HMGA1 (34) or b-galactosidase. 10 5 transfected cells were plated out for selection, using 100 mg/ml zeocin (Invitrogen). After 3 weeks of selection, colonies were stained and counted as described previously (2) . Transfectability of the C1 cell line is lower than that of the VA1 line, which was determined by transfection of a GFPexpressing plasmid. Therefore, transpositional ef®ciencies in the two cell lines presented in Figure 1B have been normalized to transfection ef®ciencies.
RESULTS

HMGB1 is required for ef®cient SB transposition in mouse cells
We assessed the importance of HMGB1 for SB transposition by applying an in vivo transposition assay (2) on wild-type and HMGB1-de®cient mouse cells (Fig. 1) . The assay is based on cotransfection of a donor plasmid carrying a zeocin resistance gene (zeo)-marked transposon and a transposase-expressing helper plasmid into cultured cells (Fig. 1A) . In control experiments, a plasmid expressing b-galactosidase (CMVb) substitutes for the transposase helper plasmid. Cells are placed under antibiotic selection, and the numbers of resistant colonies counted. The ratio between numbers obtained in the presence versus the absence of transposase is the read-out of the assay, and is a measure of the ef®ciency of transposition. Consistent with our earlier ®ndings (30), transposition was readily detectable in the wild-type MEF cell line VA1 (~3-fold increase in colony number in the presence of transposase) (Fig. 1B) . However, colony numbers obtained in HMGB1-de®cient C1 cells were not signi®cantly different in the presence and absence of transposase, indicating a severe drop in transposition ef®ciency. In order to con®rm that the effect is speci®c for the lack of HMGB1 protein in C1 cells, a plasmid expressing human HMGB1 was cotransfected together with the transposon vectors. Exogenous over-expression of HMGB1 increased colony numbers~4-fold (Fig. 1B) , which not only rescues but exceeds wild-type transpositional rates. The effect of HMGB1 in this experiment is speci®c for the transposition reaction, because in the absence of transposase HMGB1 did not increase the number of zeo-resistant colonies in the C1 cell line (data not shown). We tested the speci®city of complementation by cotransfecting plasmids expressing two other members of the HMG family, HMGB2 and HMGA1. HMGB2 showed partial complementation, consistent with its structural similarity and functional overlap with HMGB1 (12,13), whereas HMGA1 had no signi®cant effect on the ef®ciency of transposition (Fig. 1B) .
Transient over-expression of HMGB1 in wild-type cells was shown to enhance the biological activity of several proteins that interact with HMGs, including the V(D)J recombinase RAG1/2 (25) . Therefore, we cotransfected wild-type MEFs with the transposon system together with plasmids expressing HMGB1, HMGB2 or HMGA1. A pattern of transpositional enhancement similar to that in the HMGB1-de®cient C1 cell line was observed: HMGB1 had the most pronounced effect by increasing transposition~2.5-fold (Fig. 1B) . Over-expression of HMGB2 had a smaller effect, and increased the numbers of resistant colonies by~1.5-fold, whereas overexpressing HMGA1 resulted in no change in colony numbers (Fig. 1B) . Taken together, these results establish that HMGB1 is required for ef®cient DNA transposition in mouse cells, and that HMGB1 is a limiting factor of transposition in wild-type cells. 
HMGB1 enhances bending of the SB transposon terminal IR and the full length transposon
Upon binding to DNA, HMG proteins induce conformational changes in the DNA, thereby facilitating juxtaposition of distantly bound proteins and assembly of multiprotein complexes (11, 12) . SB has two transposase-binding sites per terminal IR, separated by~160 bp spacer regions. We hypothesized that the bending activity of HMGB1 could contribute to bringing the DRs and/or the complete IRs closer in space, thereby assisting the formation and/or stabilization of a synaptic complex.
To address this question, a ligase-mediated circularization assay (18) was performed on a DNA fragment comprising the left IR of the transposon. This assay measures the effect of HMGB1 on intramolecular ligation (circularization) of relatively short, and thus rigid, linear DNA molecules. The bending activity of HMGB1 results in enhanced juxtaposition of DNA ends, and therefore in enhanced circle formation by ligation. The radioactively labeled transposon IR fragment was incubated with T4 DNA ligase for different periods of time. The experiment was performed using a low concentration of ligase and, under these conditions, no ligation products were detected in the absence of HMGB1 even after 60 min of incubation (Fig. 2, lane 5) . In contrast, in the presence of HMGB1, ligation products began to appear after 15 min of incubation (lanes 8±10 in Fig. 2) . Production of DNA circles was veri®ed by treating the 60 min sample with ExoIII, which cleaves linear DNA but leaves circular DNA intact. Two ligation products were resistant to ExoIII treatment (Fig. 2,  lane 11) , con®rming the presence of circular DNA molecules. These results show that HMGB1 has a profound ability to bend a DNA fragment containing the transposon IR.
A different assay was utilized to investigate HMGB1-induced bending of a complete transposon. This assay is based on circularization of linear DNA molecules by T4 DNA ligase, and subsequent transformation into bacteria. Because of the enhanced ability of circular DNA to transform E.coli, the number of bacterial colonies serves as a measure of the ef®ciency of the ligation reaction. An SB transposon containing zeo and an origin of replication was used for this experiment (Fig. 3A) . The linear transposon was treated with T4 ligase in the absence and presence of HMGB1 for different periods of time. As shown in Figure 3B , the average number of bacterial colonies was signi®cantly higher in samples containing HMGB1.
We conclude that HMGB1-induced bending has the potential to assist the SB transposase during synaptic complex formation either by bringing the transposon binding sites and/ or the terminal repeats physically closer to each other.
HMGB1 enhances the DNA-binding activity of the SB transposase
DNA transposition is a complex process that begins with sequence-speci®c binding of the transposase to sites within the transposon IRs. We hypothesized that, in addition to its DNAbending activity shown in Figures 2 and 3, HMGB1 stimulates transposition by enhancing transposase binding to the IRs.
Histidine-tagged versions of both the N-terminal DNAbinding domain of the SB transposase (N123) and HMGB1 were puri®ed from E.coli using af®nity chromatography. The left IR, containing two transposase-binding sites, was radioactively labeled and used as a probe in an EMSA (Fig. 4) . As shown previously (2), N123 produced two shifted bands, representing complexes in which either one (complex C1) or both sites (complex C2) are bound (Fig. 4A, lane 2) . HMGB1 enhanced binding of N123, indicated by a more prominent formation of C2 (Fig. 4A, lane 3) . The enhancement was inversely dependent on the concentration of N123 relative to that of HMGB1; stimulation of binding was~2-fold at 30 nM N123 (Fig. 4A, lane 3) , 5-fold at 15 nM N123 (Fig. 4A, lane  5) , and >7-fold at 7.5 nM N123 (Fig. 4A, lane 7) , as judged by comparing the total bound radioactivity (sum of bands C1 and C2) to the unbound, free probe in the presence and absence of HMGB1. In this assay, HMGB1 alone did not shift the probe when added at 75 nM concentration (data not shown). HMGB1 did not produce a supershift either, indicating that a ternary complex containing the DNA probe, N123 and HMGB1 is unstable, at least under the conditions used in the assay.
Next, the effect of HMGB1 on transposase binding to IR probes carrying only a single transposase binding site was tested in an EMSA. The ODR is located next to the transposase cleavage site, whereas the IDR is~200 bp from the end of the transposon. The IDR and ODR are not identical, they share~80% sequence identity and the IDR is shorter by 2 bp (Fig. 4B ). There appeared to be a clear preference for the IDR in transposase binding, because N123 bound to it~3-fold stronger than to the ODR (compare lanes 2 and 6 in Fig. 4C ). The presence of HMGB1 appeared to further emphasize this preference for IDR binding: at 75 nM concentration of HMGB1, N123 shifted~90% of the IDR probe (Fig. 4C, lane  8) , but only~50% of the ODR probe (Fig. 4C, lane 4) . HMGB1 alone did not shift either probe (Fig. 4C, lanes 3 and  7) . Taken together, these data show that HMGB1 stimulates transposase binding to the transposon IRs, and that it has a more pronounced effect on binding to the IDR.
SB transposase physically interacts with HMGB1
Since HMGB1 has no sequence speci®city on its own, it has to be actively recruited to speci®c sites by other DNA-binding proteins (12) . To investigate possible physical interactions between the SB transposase and HMGB1, an immunoprecipitation experiment was performed (Fig. 5) . Nuclear extracts were prepared from HeLa cells constitutively expressing the SB transposase. An antibody against human HMGB1 or a matched preimmune serum was used for immunoprecipitation. Precipitated proteins were subsequently blotted and hybridized with a polyclonal antibody against SB transposase. SB transposase was coprecipitated with the HMGB1 antibody, but not with the preimmune serum (Fig. 5, lanes 1 and 2) . Treating the nuclear extract with DNase I did not in¯uence the formation of the immunocomplex (compare lanes 2 and 3 in Fig. 5 ), indicating that the detected signal was not due to non-speci®c, simultaneous binding of SB and HMGB1 to genomic DNA. Furthermore, interaction between HMGB1 and SB transposase is not dependent on the presence of transposon DNA, because immunoprecipitation in the presence or absence of DNA gave similar results (data not shown). Control nuclear extracts did not produce a signal (Fig. 5, lane 4) ; thus, immunoprecipitation is dependent on the presence of SB transposase. Treatment of nuclear extracts with actin and p15 antibodies failed to immunoprecipitate SB transposase (Fig. 5, lanes 5  and 6) , indicating that the interaction observed is speci®c for HMGB1. Similar results were obtained when puri®ed HMGB1 protein was immobilized on agarose beads, and incubated with puri®ed SB protein (data not shown). We conclude that the transposase actively interacts with HMGB1.
Formation of a ternary complex of transposon DNA, SB transposase and HMGB1
The activity of HMGB1 at the transposon IRs necessitates the temporary existence of a nucleoprotein complex containing the transposon IRs, the transposase and HMGB1. We considered that the full-length transposase protein is required for either the formation or stability of such a complex. Because production of recombinant, full-length SB transposase is dif®cult due to insolubility problems, a maltosebinding protein±SB transposase fusion protein (MBP±SB) was expressed in E.coli, and puri®ed. MBP±SB was ®rst tested for DNA-binding activity in an EMSA experiment, using the same IR probe as in Figure 4A . HMGB1 enhanced the binding ef®ciency of MBP±SB more than two times (Fig. 6A, compare  lanes 2 and 3) . HMGB1 alone did not shift the probe (Fig. 6A,  lane 4) . The most ef®cient enhancement of DNA binding was observed when HMGB1, MBP±SB and DNA were added to the reaction at a molar ratio of 5:1:0.05 (Fig. 6A, lane 3 and data not shown). We concluded that the MBP±SB fusion protein was active in binding to the transposon IRs, and that, as observed before, HMGB1 stimulated this binding.
Next we sought evidence for a ternary complex using MBP±SB in a coimmunoprecipitation experiment. Radioactively labeled transposon IR DNA was incubated with MBP±SB and HMGB1, and coimmunoprecipitated with either anti-SB or anti-HMGB1 antibodies. Figure 6B shows that the anti-SB antibody precipitated about three times more DNA±transposase complexes when HMGB1 was present in the reaction, consistent with our ®ndings that HMGB1 enhances binding of the transposase to transposon DNA. The anti-HMGB1 antibody did not coimmunoprecipitate DNA when MBP±SB or HMGB1 were added alone to the probe. However, the anti-HMGB1 antibody did coimmunoprecipitate DNA in the presence of both MBP±SB and HMGB1 (Fig. 6B) . In contrast, N123 was not able to form a ternary complex (data not shown). These results show that HMGB1 can form a ternary complex with MBP±SB and transposon DNA. Because the catalytic steps of DNA transposition require Mg 2+ as a cofactor (27) , and because ternary complex formation in our experiments was observed in a Mg 2+ -free buffer, we conclude that a likely role of HMGB1 in transposition is realized prior to catalysis, most likely during synaptic complex assembly.
DISCUSSION
In this work we presented evidence that HMGB proteins are cellular cofactors of SB transposition. In HMGB1 knockout cells, transpositional activity was found to be marginal (Fig. 1B) . This residual activity can probably be accounted for by the presence of HMGB2 in these cells (33) . HMGB2 was found to partially or fully complement the absence of HMGB1 in some reactions (12) , so these two proteins are interchangeable to a certain degree. Indeed, transient overexpression of HMGB2 partially complemented the HMGB1 de®ciency in our transposition assays (Fig. 1B) . Mammalian cells contain signi®cant amounts of HMGBs; there might be one molecule of HMGB1 for every 2 kb of the human genome (35) . Therefore, our ®nding that transient over-expression of HMGBs in wild-type mouse cells enhances transposition (Fig. 1B) was unexpected. However, this phenomenon is not without precedent: transient over-expression of HMGB1 by transfection enhances the activity of certain HMGB1 interactors, such as RAG1/2 (24), some Hox proteins (21) , and nuclear hormone receptors (36) . Our ®ndings suggest that HMGB1 can be a limiting factor of SB transposition, and that 
Possible roles of HMGB1 in transposition
In prokaryotes, the DNA-bending proteins HU and IHF bind directly to DNA, and no protein±protein interactions are required for their targeting (7) . In contrast, HMGs have low af®nity for standard, B-form DNA, and interactor proteins usually guide them to certain sites. We have shown that the SB transposase is an HMG interactor (Figs 5 and 6 ). The interaction was detectable in the absence of DNA, suggesting that SB might actively recruit HMGB1 to sites of transposition. At which step is HMGB1 required for transposition? We considered the following, not mutually exclusive, possibilities: (i) HMGB1 induces a structural change in transposon DNA, which is required for ef®cient transposition; (ii) HMGB1 enhances binding of the transposase to the transposon IRs; (iii) HMGB1 induces a conformational change of the transposase that makes the transposase more active; (iv) HMGB1 plays a role in transposon integration by making contacts with chromatin components and/or by DNA-bending at target sites (37) . In this paper we provided evidence that HMGB1 promotes circle formation of transposon DNA ( Figs  2 and 3) , that it signi®cantly enhances speci®c transposase binding to the transposon IRs (Fig. 4) , and that it can form a ternary complex with the transposase and transposon DNA (Fig. 6) . Thus, although a role of HMGB1 in transposon integration cannot be ruled out, our results are consistent with a role of HMGB1 in the early steps of transposition, prior to catalysis.
Considering the signi®cant drop of transposition activity in HMGB1-de®cient cells (Fig. 1B) , the role of HMGB1 in transposition has to be a critical one. SB has four transposasebinding sites, directly repeated at the ends of the terminal IRs. We have previously shown that: (i) presence of the four transposase binding sites is absolutely required for transposition (30) and (ii) SB transposase forms tetramers in complex with transposase-binding sites (4). These observations are consistent with an interaction between the IR/DR structure and a transposase tetramer during transposition. We propose that one of HMGB1's roles is to bring the two binding sites closer to each other during synaptic complex formation (Fig. 7) . HMGB1 might promote communication between DNA motifs that are otherwise distant to each other, including the DRs, the transpositional enhancer and the two IRs (Fig. 7) . Similar to SB transposition, a DNA-bending protein, HU, is involved in looping out the linker DNA between transposase binding sites during Mu-transpososome assembly (7) . If the only role of HMGB1 is to extrude the spacer region between the DRs, thereby bringing them close to each other in space, then deleting the spacer would rescue transposition activity even in the absence of HMGB1. We have constructed transposons, in which the DRs were 10, 20 and 50 bp from each other. None of these transposons had any detectable activity (data not shown), indicating that physical proximity of the DRs is not suf®cient for transposition, and that the correct geometrical con®guration of the IRs and the binding sites is crucial.
These observations indicate that a highly speci®c con®g-uration of functional DNA elements within the IRs has a critical importance in SB transposition (Fig. 7) . This complex needs to be very precisely assembled, and probably includes the four DRs, the HDR enhancer motif, four transposase molecules (4) and HMGB1 (Fig. 7) . Because transposase has higher af®nity to the internal binding sites within the transposon IRs (Fig. 4C ), it appears that the order of events that take place during the very early steps of transposition is binding of transposase molecules ®rst to the inner sites, and then to the outer sites. The pronounced effect of HMGB1 on binding of the transposase to the inner sites suggests that HMGB1 enforces ordered assembly of a catalytically active synaptic complex. If any of these molecular requirements is not ful®lled properly, the transposition reaction is hampered or does not proceed at all. Indeed, replacement of the outer transposase binding sites with the inner sites, i.e. increasing binding at the outer sites, abolishes SB transposition (38) . An assembly pathway similar to the one we propose for SB has been described for bacteriophage l. The integrase protein, together with IHF, ®rst assembles on a high af®nity attachment site (attP) on the phage genome (39) , and then captures another, low af®nity site on the bacterial chromosome (attB) (40) . In this system, the order of assembly is determined by the difference in af®nity of the integrase for the attP and attB sites.
HMGB1 has overlapping, but distinct roles in V(D)J recombination and SB transposition
In V(D)J recombination, the RAG1/2 complex speci®cally binds to the nonamer and heptamer motifs of the RSSs (Fig. 4B) , which are separated by 12 or 23 bp spacer regions (12/23-RSS). V(D)J recombination preferentially takes place between a 12-RSS and a 23-RSS, which is termed the 12/23 rule (24, 25, 41) . HMGB1/2 signi®cantly stimulates the binding of both RSSs, but this stimulation is especially pronounced at the 23-RSS (24) . This selective enhancement of binding is thought to enforce the speci®city of the subsequent cleavage step (24, 25) . Recent results indicate that the RAG1/2 complex ®rst assembles on a single RSS, and that the partner RSS is later incorporated into the complex as naked DNA (42) . Initial binding of RAG1/2 to the 12-RSS results in more faithful adherence to the 12/23 rule. Because there is no substantial difference in the binding af®nity of RAG1/2 for naked 12-and 23-RSSs in the presence of HMGB proteins, it has been suggested that chromatin structure may in¯uence whether RAG1/2 binds ®rst to a 12-or a 23-RSS in vivo (42) .
The transposase-binding sites of SB resemble the RSSs in their sequence (Fig. 4B) . Similarly to the RSSs, the spacing between the nonamer and heptamer-like motifs within the transposase-binding sites is different, 12 and 14 bps, in the internal and external DRs, respectively. We have found that SB transposase preferentially binds the IDR (12DR) (Fig. 4C) . The 2 bp difference in spacer length between 12DR and 14DR might not be suf®cient for HMGB1 to assert its DNA-bending activity to promote transposase binding. More likely, the helical phasing of the heptamer-and nonamer-like sequences in 14DR might be less favorable for transposase binding. In contrast to V(D)J recombination, the original preference of the SB transposase for binding to the 12DR is not altered, but even further emphasized in the presence of HMGB1 (Fig. 4C ). In conclusion, HMGB1 seems to have overlapping, but distinct roles in SB transposition and in V(D)J recombination.
The IR/DR-type organization of IRs is an evolutionarily conserved feature of many transposons in the Tc1 family (1), but its function in transposition has been enigmatic. Our results suggest that the IR/DR introduces a higher level regulation into the transposition process: the repeated transposase binding sites, their dissimilar af®nity for the transposase, and the effect of HMGB1 to differentially enhance transposase binding to the inner sites are all important for a geometrically and timely orchestrated formation of synaptic complexes, which is a strict requirement for the subsequent catalytic steps of transposition.
